Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network.
Lung Cancer., Dec;78(3):245-52 (2012)
Evidence gaps in advanced cancer care: community-based clinicians' perspectives and priorities for comparative effectiveness research.
J Oncol Pract., May;8(3 Suppl):28s-33s (2012)
High-cost imaging in elderly patients with stage IV cancer.
J. Natl. Cancer Inst., Aug;104(15):1164-72 (2012)
Evidence gaps in advanced cancer care: community-based clinicians' perspectives and priorities for CER.
Am J Manag Care., May;18(5 Spec No. 2):SP77-83 (2012)
Validation of Electronic Data on Chemotherapy and Hormone Therapy Use in HMOs.
Med Care., Apr (2012)
NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine.
PLoS ONE., 7(2):e32165 (2012)
NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma.
Cancer., Sep;118(18):4564-70 (2012)
Immune-based therapies for sarcoma.
Sarcoma., 2011:438940 (2011)
Provision of spiritual care to patients with advanced cancer: associations with medical care and quality of life near death.
J. Clin. Oncol., Jan;28(3):445-52 (2010)
Racial differences in predictors of intensive end-of-life care in patients with advanced cancer.
J. Clin. Oncol., Nov;27(33):5559-64 (2009)